1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 14

    Field tests of loss-of-function tobacco lines of eIF(iso)4E for resistance to tobacco bushy top disease and agronomic traits

    KOGA K.(1); SHINJO A.(1); MAINJENI C.E.D.(2); MSANGOSOKO K.R.(2); UDAGAWA H.(1); TAKAKURA Y.(1)
    (1) Japan Tobacco Inc., Leaf Tobacco Research Center, Oyama, Tochigi, Japan; (2) Agricultural Research and Extension Trust, Department of Research and Technical Services, Lilongwe, Malawi
    Tobacco bushy top disease (TBTD) is one of the serious diseases affecting tobacco (Nicotiana tabacum L.) production in African countries such as Malawi, Zambia, Tanzania and Ethiopia. This disease is caused by a mixed infection of tobacco bushy top...
  2. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, APPOST 13

    Agronomic and qualitative performance of some experimental Burley hybrids in Malawi

    CHAMANGO A.M.Z.; SIBANDE L.A.G.O.; MATEWELE M.
    Agricultural Research and Extension Trust (ARET), Lilongwe, Malawi
    Malawi mainly depends on tobacco for forex generation, with Burley as a major contributor. However, the country has a limited choice of high yielding and disease resistant varieties against a plethora of disease constraints, particularly root-knot...
  3. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, APPOST 14

    Forestry sustainability in the tobacco sector in Malawi: a community concern requiring community approaches

    OFESI H.K.T.; LIVIMBO S.S.
    Agricultural Research and Extension Trust (ARET), Lilongwe, Malawi
    Tobacco farmers depend heavily on tree resources for poles and firewood used in curing. Malawi tobacco farmers predominantly grow Burley tobacco which requires the least amount of tree resources per unit volume in comparison to dark-fired and...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 09

    The ABOUT™ Toolbox: toward the development of consumer-reported outcome measures that matter

    CHREA C.(1); SPIES E.(1); AFOLALU E.(1); BACSO A.(1); CLERC E.(1); MAINY N.(1); BINGGELI P.(1); WEITKUNAT R.(1); ACQUADRO C.(2); SALZBERGER T.(3); CANO S.(4); ABETZ-WEBB L.(5); ROSE J.(6)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) Mapi, an ICON plc Company, Lyon, France; (3) University of Economics and Business, Vienna, Austria; (4) ScaleReport, Ltd, Stotfold, U.K.; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.; (6) Rose Research Center, Raleigh, U.S.A.
    Tobacco harm reduction promotes the substitution of reduced-risk products (RRPs) for cigarettes by adult smokers who would otherwise continue to smoke, while preventing RRP initiation among non-users. To operationalize this public health strategy,...
  5. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 11

    Development and validation of the ABOUT™–Dependence measurement instrument to assess perceived dependence on tobacco and nicotine products

    AFOLALU E.(1); CHREA C.(1); SALZBERGER T.(2); ABETZ-WEBB L.(3); CANO S.(4); WEITKUNAT R.(1); ROSE J.(5)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) University of Economics and Business, Vienna, Austria; (3) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.; (4) Modus Outcomes, Letchworth Garden City, U.K.; (5) Rose Research Center, Raleigh, U.S.A.
    The development of the ABOUT™–Dependence measurement instrument was initiated to enable assessment of perceived dependence associated with the use of different tobacco and nicotine products (TNPs) and in users of multiple TNPs. We initially developed...
  6. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 23 (also presented at TSRC 2019)

    Functional filter plug wrap paper for control of the thermal energy of the aerosol from heated tobacco products (HTPs)

    LINDNER M.; LEICHSENRING N.
    (1) TANNPAPIER GmbH, Traun, Austria; (2) Hauni Maschinenbau GmbH, Hamburg, Germany
    Next generation products, which include all kinds of e-vapour items as well as heated tobacco products (HTPs or “heat sticks”), have successfully entered the tobacco market in addition to conventionally combustible cigarettes. From the basic...
  7. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 49

    The CORESTA in vitro test battery for combustible tobacco products: update from the 2004 Rationale and Strategy Report

    LEE K.M.(1); JORDAN K.G.(2); WIECZOREK R.(3); MOENNIKES O.(4); CLEMENTS J.(5); CROOKS I.(6); HASHIZUME T.(7); MILLER J.(8); WEBER E.(9); YOSHINO K.(7)
    (1) Altria Client Services, Richmond, VA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.; (3) Imperial Brands, Reemtsma Cigarettenfabriken GmbH, Hamburg, Germany; (4) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (5) Covance Laboratories Ltd, Harrogate, U.K.; (6) British American Tobacco (Investments) Ltd, R&D, Southampton, U.K.; (7) Japan Tobacco Inc., Yokohama, Kanagawa, Japan; (8) JT International SA, Geneva, Switzerland; (9) Ökolab, Vienna, Austria
    In 2004, the CORESTA In Vitro Toxicity Task Force issued a rationale and strategy report, commonly known as “the CORESTA in vitro test battery guideline”. The goals of this guideline were to: 1) develop the rationale and strategy for conducting in...
  8. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 57

    Cross-cultural equivalence of the ABOUT™–Perceived Risk instrument in seven languages

    CHREA C.(1); CANO S.(2); SALZBERGER T.(3); MAINY N.(1); ACQUADRO C.(4); POPIELNICKI A.(5); WEITKUNAT R.(1)
    (1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Modus Outcomes, Letchworth Garden City, U.K.; (3) University of Economics and Business, Vienna, Austria; (4) Mapi Research Trust, ICON plc, Lyon, France; (5) TransPerfect, Linguistic Validation Group, Boston, MA, U.S.A.
    The risk of smoking has long been well understood by consumers. However, it is important to measure the perceived risks by consumers of novel smoke-free alternatives to cigarettes. The ABOUT™–Perceived Risk instrument was developed to allow the...
  9. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 012

    Real-time monitoring of volatile organic compounds and aerosol in exhaled breath from inhalation of vapor products and combustible cigarettes

    O'REGAN D.C.(1); OZVALD A.M.(1); HEINE N.(1); GUTMANN R.(2); ROSENKRANZ B.(2)
    (1) JUUL Labs, San Francisco, CA, USA; (2) Ionicon, Innsbruck, Austria
    Exhaled breath (EB) analysis is an attractive methodology for clinical studies, due to its non-invasive nature. Analysis of Volatile Organic Compounds (VOCs) in exhaled breath may facilitate diagnosis of pathological conditions, including potential...